
Fluoxetine
Fluoxetine is a long-acting SSRI antidepressant approved for depression, OCD, bulimia nervosa and panic disorder. Trials show it works better than placebo, with a modest average effect in adult depression and good tolerability. Because it stays in the body for weeks, serotonin-raising supplements such as St. John's wort, 5-HTP and tryptophan are a concern during treatment and for several weeks after stopping.
Prescription medication: not a dietary supplement
This is an FDA-approved (or investigational) drug, not a supplement. It requires a prescription and medical supervision. The information below summarizes clinical-trial evidence for education only. It is not a recommendation to obtain or use it without a doctor.
Quick decision guide
May help most
Adults with depression, OCD, bulimia nervosa or panic disorder, and children or teens with depression (from age 8) or OCD (from age 7), treated by a prescriber
Common dosing range
Set by a prescriber. Labeled adult starting doses are 20 mg each morning for depression and OCD, 10 mg daily for panic disorder (raised to 20 mg after a week), and 60 mg daily for bulimia nervosa; the label maximum is 80 mg per day
When to expect effects
Full effect may take 4 weeks or longer for depression and 5 weeks or longer for OCD, according to the label
Watch out for
Serotonin syndrome with other serotonin-raising drugs and supplements, a risk that persists for weeks after the last dose; higher bleeding risk with aspirin, NSAIDs and warfarin; low blood sodium; never combine with MAOIs, pimozide or thioridazine; raises levels of many drugs cleared by CYP2D6
What is it
Fluoxetine is a prescription antidepressant in the selective serotonin reuptake inhibitor (SSRI) class. It was first approved in the US in 1987 and is sold as Prozac and as generic capsules and tablets. The FDA label lists major depressive disorder (acute and maintenance), obsessive-compulsive disorder (OCD), bulimia nervosa and panic disorder, and use together with olanzapine for bipolar depression and treatment-resistant depression. It carries the boxed warning shared by all antidepressants about suicidal thoughts and behaviors in children, teens and young adults. Fluoxetine stands out for how long it stays in the body: it and its active breakdown product, norfluoxetine, linger for weeks, so supplement interactions can still matter after the last dose.
Is it worth it for you?
Use this as a quick fit check, not a diagnosis.
Worth considering if…
Probably skip if…
Evidence at a glance
| Goal | Effect | Best fit | Time |
|---|---|---|---|
major depressive disorder in adults Good Evidence | Modest; better than placebo, but less effective than several other antidepressants in head-to-head trials | Adults with diagnosed major depression for whom tolerability matters | 4 weeks or longer for full effect |
depression in adolescents Limited Evidence | Moderate to large; 60.6% response alone and 71.0% with CBT vs 34.8% on placebo | Teens with major depression, especially when CBT is added | Measured at 12 weeks |
obsessive-compulsive disorder (OCD) Limited Evidence | Moderate; 4.6 to 6.5 point drop in Y-BOCS vs 0.9 on placebo | Adults with OCD lasting a year or more | Measured at 13 weeks; the label says full effect may take 5 weeks or longer |
bulimia nervosa Limited Evidence | Moderate at 60 mg per day; smaller at 20 mg | Adult women with bulimia nervosa, at the 60 mg dose | Measured at 8 weeks |
major depressive disorder in adults
- Effect
- Modest; better than placebo, but less effective than several other antidepressants in head-to-head trials
- Best fit
- Adults with diagnosed major depression for whom tolerability matters
- Time
- 4 weeks or longer for full effect
depression in adolescents
- Effect
- Moderate to large; 60.6% response alone and 71.0% with CBT vs 34.8% on placebo
- Best fit
- Teens with major depression, especially when CBT is added
- Time
- Measured at 12 weeks
obsessive-compulsive disorder (OCD)
- Effect
- Moderate; 4.6 to 6.5 point drop in Y-BOCS vs 0.9 on placebo
- Best fit
- Adults with OCD lasting a year or more
- Time
- Measured at 13 weeks; the label says full effect may take 5 weeks or longer
bulimia nervosa
- Effect
- Moderate at 60 mg per day; smaller at 20 mg
- Best fit
- Adult women with bulimia nervosa, at the 60 mg dose
- Time
- Measured at 8 weeks
Evidence for 4 uses
AI-assisted evidence assessment. Talk to your doctor before relying on any single supplement.
major depressive disorder in adults
Disease adjunctA 2018 network meta-analysis of 522 double-blind trials in 116,477 adults with acute major depression found all 21 antidepressants studied, fluoxetine included, more effective than placebo. Fluoxetine was one of only two drugs with fewer dropouts than placebo (odds ratio 0.88), which suggests good tolerability. In head-to-head trials, however, fluoxetine was among the less effective antidepressants. The authors rated certainty moderate to very low.
Bottom line: Fluoxetine works better than placebo for adult depression and is well tolerated, though some other antidepressants did better head to head.
depression in adolescents
Disease adjunctThe Treatment for Adolescents With Depression Study (TADS) randomized 439 teens aged 12 to 17 with major depression to fluoxetine (10 to 40 mg per day), cognitive behavioral therapy (CBT), both, or placebo for 12 weeks. Response rates were 71.0% with fluoxetine plus CBT, 60.6% with fluoxetine alone, 43.2% with CBT alone and 34.8% with placebo. Suicidal thinking, present in 29% at the start, improved in all groups; 7 of 439 teens (1.6%) attempted suicide and none died.
Bottom line: For depressed teens, fluoxetine helps, and combining it with CBT worked best.
obsessive-compulsive disorder (OCD)
Disease adjunctTwo identical 13-week placebo-controlled trials in 355 outpatients aged 15 to 70 with OCD tested fixed doses of 20, 40 and 60 mg per day. All three doses reduced OCD severity more than placebo: the Yale-Brown score fell by 4.6, 5.5 and 6.5 points versus 0.9 with placebo, with a trend toward greater benefit at 60 mg. Most patients (79.2%) completed the trials.
Bottom line: Fluoxetine reduces OCD symptoms, with a trend toward more benefit at higher doses.
bulimia nervosa
Disease adjunctAn 8-week multicenter trial in 387 women with bulimia nervosa compared fluoxetine 60 mg and 20 mg daily with placebo. The 60 mg dose reduced weekly binge-eating and vomiting episodes more than placebo; 20 mg gave an effect between the two. Depression, carbohydrate craving and unhealthy eating attitudes also improved. Insomnia, nausea, weakness and tremor were more common on fluoxetine, but dropouts for side effects did not differ.
Bottom line: At 60 mg a day, fluoxetine cut binge-eating and vomiting episodes in an 8-week trial.
How it works
How to take it
What to track
Bottom line: A prescriber sets the dose and any change to it; remember that fluoxetine's interactions can outlast the last capsule by weeks.
Safety
Know the common side effects, key cautions, and who should avoid it.
Common side effects
Serious risks
Boxed warning: increased suicidal thinking and behavior in children, teens and young adults taking antidepressants; the label asks for monitoring for worsening and new suicidal thoughts
Serotonin syndrome, potentially life-threatening, especially with other serotonergic drugs and supplements such as tryptophan and St. John's wort; because of the long half-life, the risk continues for weeks after stopping
Increased bleeding risk, higher with aspirin, NSAIDs, warfarin and other drugs that affect clotting
Low blood sodium (hyponatremia), with headache, poor concentration, confusion, weakness and unsteadiness; older adults and people on diuretics are at higher risk
QT prolongation and dangerous heart rhythms including torsades de pointes; mania in people with bipolar disorder; seizures; angle-closure glaucoma; allergic reactions and rash; significant weight loss in underweight patients
Who should avoid it
- People taking an MAOI antidepressant or who stopped one within 14 days, and people being given linezolid or intravenous methylene blue; MAOIs must also wait 5 weeks after fluoxetine is stopped
- People taking pimozide or thioridazine, or within 5 weeks of stopping fluoxetine for thioridazine
- People with heart rhythm risks (long QT, very slow heart rate, low potassium or magnesium) need extra caution and a prescriber's review
Pregnancy & breastfeeding
Talk to your prescriber before or as soon as you plan or confirm a pregnancy; the label notes that women who stopped antidepressants in pregnancy were more likely to relapse. Published studies over several decades have not established an increased risk of major birth defects or miscarriage. Use late in pregnancy has been linked to newborn complications and to persistent pulmonary hypertension of the newborn, and SSRI use in the month before delivery to a less than 2-fold higher risk of heavy bleeding after birth. Fluoxetine passes into breast milk, and there are reports of agitation, irritability, poor feeding and poor weight gain in breastfed infants, so infants should be watched for these.
Interactions
The Prozac label names St. John's wort among the products that raise the risk of serotonin syndrome, a reaction that can be life-threatening, and a 2007 case report described serotonin syndrome with muscle breakdown in a patient taking fluoxetine, St. John's wort and migraine triptans. A systematic review also found St. John's wort lowers the levels of many medicines by inducing liver enzymes. Do not combine them, including in the weeks after stopping fluoxetine, and let your prescriber guide any switch.
5-HTP is turned directly into serotonin and adds to fluoxetine's effect. A published case described serotonin syndrome in a man taking another SSRI (sertraline) with supplements that included 5-HTP. Do not take 5-HTP with fluoxetine or in the weeks after stopping it unless your prescriber directs it, and seek urgent care for tremor, sweating, agitation, fever or a racing heart.
The Prozac label lists tryptophan as a serotonin syndrome risk, and its Medication Guide names over-the-counter tryptophan among products to tell your doctor about. Fluoxetine's long half-life means the risk lasts for weeks after the last dose. Check with your doctor or pharmacist before starting any tryptophan product.
Contraindicated by the label because of serotonin syndrome risk. Wait 14 days after stopping an MAOI before starting fluoxetine, and 5 weeks after stopping fluoxetine before starting an MAOI.
Contraindicated by the label because of QT prolongation and, for thioridazine, raised blood levels. Thioridazine must not be used within 5 weeks of stopping fluoxetine.
Kava can cause liver injury in some people, with overdose, long use and other medicines among the risk factors, and it has sedative effects. A 2025 case report described prolonged serotonin syndrome in a teenager taking kava with two SNRI antidepressants (not fluoxetine), and its authors advise limiting kava while taking certain serotonergic medicines; no study has tested kava with fluoxetine itself. The cautious choice is to avoid kava with fluoxetine unless your doctor or pharmacist agrees, and to report yellow skin or eyes, dark urine or unusual tiredness promptly.
A 2024 case report described a 20-year-old on fluoxetine 40 mg and lithium who came to hospital three times in 3 weeks with serotonin syndrome. The first visit followed an overdose; the other two began within hours of using high-THC cannabis oil or a THC vape. Tell your prescriber about any cannabis use and treat agitation, fever, tremor or a racing heart after use as an emergency.
SAM-e has antidepressant activity of its own, a 1993 report described a toxic reaction when it was combined with the antidepressant clomipramine, and a 2018 case report described mania when it was taken with an SSRI. In a supervised 6-week trial in people whose depression had not responded to a serotonin reuptake inhibitor antidepressant, adding SAM-e was tolerated, which shows it is something to use only under a prescriber's oversight. Do not add it on your own, including in the weeks after stopping fluoxetine.
Fluoxetine raises bleeding risk, and the label says these medicines may add to it, including stomach and gut bleeding. Ask your doctor or pharmacist before using over-the-counter pain relievers regularly.
The Prozac Medication Guide says not to drink alcohol while using it, and the label warns that fluoxetine can impair judgment, thinking and motor skills. Because fluoxetine stays in the body for weeks, spacing drinks away from the dose does not avoid the interaction. Discuss your drinking with your doctor or pharmacist.
Saffron has antidepressant effects in trials, possibly through serotonin, so it may add to fluoxetine in theory. In an 8-week trial in adults already taking antidepressants, adding a standardized saffron extract did not worsen antidepressant side effects. Discuss a saffron supplement with your prescriber first; saffron in food is not the concern.
Documented interactions
Evidence-graded pair pages with sources, dosing notes, and timing guidance, a complement to the narrative section above.
Warnings (7)
+ 5-htp
criticalFluoxetine is an SSRI that blocks serotonin reuptake, and 5-HTP is a direct precursor the body converts into serotonin. Combining them can push serotonin to levels associated with serotonin syndrome, and fluoxetine's long-lived active metabolite norfluoxetine extends this risk for weeks after the last dose.
+ st. john's wort
criticalFluoxetine and St. John's wort both increase serotonin activity, and the Prozac label lists St. John's wort among the products that raise the risk of serotonin syndrome, a reaction that can be life-threatening. Because fluoxetine stays in the body for weeks, the risk continues after the last dose.
+ tryptophan
criticalFluoxetine blocks serotonin reuptake while tryptophan supplies the raw material for serotonin synthesis, and the combination can produce an excitatory reaction or serotonin syndrome. Fluoxetine's long-acting active metabolite means this risk persists for weeks after the last dose.
+ kava
highKava carries a well-documented risk of serious, unpredictable liver injury and acts as a central nervous system depressant, so combining it with fluoxetine raises concern about additive sedation and liver harm. Lab studies suggested kava might block enzymes that clear fluoxetine, but in healthy volunteers kava taken for 2 to 4 weeks did not slow CYP2D6, the main enzyme that clears fluoxetine, so a rise in fluoxetine levels is not expected.
Choosing a product
What to look for on the label, and what to be skeptical of.
Look for…
Be skeptical of…
Frequently asked questions
Can I take St. John's wort with fluoxetine?⌄
No, not without your prescriber. The Prozac label names St. John's wort among products that raise the risk of serotonin syndrome. Because fluoxetine stays in the body for weeks, this applies in the weeks after stopping it too.
How long after stopping fluoxetine can I take 5-HTP or tryptophan?⌄
Ask your prescriber. The label sets no waiting time for supplements. It does say that norfluoxetine, the active breakdown product, has a half-life of 4 to 16 days, and it requires a 5-week gap before starting an MAOI, so serotonin-building supplements can still add to fluoxetine's effect for weeks after the last dose.
Is it safe to drink coffee on fluoxetine?⌄
Moderate coffee is usually fine, but caffeine can worsen the nervousness and insomnia that fluoxetine can cause. Keep it earlier in the day and cut back if you feel wired.
Can I drink alcohol while taking fluoxetine?⌄
The Prozac Medication Guide says not to drink alcohol while using it. Talk to your doctor or pharmacist about your drinking.
Does fluoxetine deplete any nutrients?⌄
It is not known to deplete a vitamin. It can lower blood sodium, especially in older adults and people on water pills, and may reduce appetite and weight. If you get headaches, confusion or unsteadiness, ask your doctor whether to check your sodium level.
References by claim
major depressive disorder in adults
Cipriani et al., 2018 · PMC (2018) link
depression in adolescents
March et al., 2004 · PubMed (2004) link
obsessive-compulsive disorder (OCD)
Tollefson et al., 1994 · PubMed (1994) link
bulimia nervosa
PMID 1550466 · PubMed (1992) link
Safety
Prozac (fluoxetine) prescribing information · DailyMed (FDA label) link
Interaction: St. John's wort (Hypericum perforatum)
Interaction: 5-HTP (5-hydroxytryptophan)
Patel et al., 2017 · PMC (2017) link
Interaction: Kava (Piper methysticum)
Interaction: Cannabis (THC products)
Nadeem et al., 2024 · PMC (2024) link
Interaction: SAM-e (S-adenosylmethionine)
Track Fluoxetine with Pilora
Set up dose reminders, check interactions, and join the community in the Pilora app.
Disclaimer: This page summarizes published clinical-trial data for educational purposes and is not medical advice or a recommendation to use this prescription medication. Dosing, eligibility, and monitoring must be decided by a licensed prescriber.
